ANTIGEN-SPECIFIC T CELL INDUCER, ANTIBODY PRODUCTION INDUCER, IMMUNE ENHANCER AND VACCINE

摘要

[PROBLEMS] To provide a novel antigen-specific T cell inducer, a novel antibody production inducer, a novel immune enhancer and a novel vaccine, as well as a novel method of inducing antigen-specific T cells, a method of inducing antibody production, a novel method of immune enhancement, a novel therapeutic method for tumor and a novel therapeutic method against a pathogen. [MEANS FOR SOLVING PROBLEMS] A complete adjuvant, which is prepared by inactivating herpes simplex virus (HSV) and adding it to an incomplete adjuvant, is used as an antigen-specific T cell inducer, an antibody production inducer or an immune enhancer. Such an antigen-specific T cell inducer, an antibody production inducer or an immune enhancer is used together with an antigen to give a vaccine. In this case, a cancer-specific antigen or a pathogen-specific antigen is used as the antigen to thereby establish a therapeutic method for tumor or a therapeutic method for pathogen infection.